Anti-GPC2 (clone LH3) SynExpress pL-R-P-X Modified CD8+ T cells

CAT#: ITS-1224-CR525
Clone: LH3
Host: humanized
Cell Source: Modified CD8+ T cells
Species Reactivity: human
Connector Fragments: pL-RFP-PAX-XbaI
Carrier Type: Retrovirus
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target GPC2 (clone LH3). We employs the Retrovirus (pL-RFP-PAX-XbaI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Delayed feedback for a robust and sustained response against cancers.
Host
humanized
Target
GPC2
Clone
LH3
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
pL
Effector Gene
PAX
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
Retrovirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Target
GPC2
Alternative Names
GPC2; Glypican 2
Gene ID
Q9H6X2(Human); Q9CZ52(Mouse)
Format
Lyophilized/Liquid
Shipping
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.
For Research Use Only | Not For Clinical Use
Online Inquiry